ClinicalTrials.gg
Not yet recruitingNCT07572786Updated May 7, 2026

Effect of Electroacupuncture on Bowel Function and Quality of Life in Postpartum Constipation: A Randomized Controlled Trial

An interventional study of electroacupuncture and abdominal exercises for constipation in Postpartum Constipation, sponsored by MTI University. Not yet recruiting. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by MTI University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

Postpartum constipation is a common condition affecting women after childbirth, leading to discomfort and reduced quality of life. Pharmacological treatments may have side effects and are sometimes avoided during breastfeeding. Electroacupuncture is a safe, non-pharmacological intervention that may improve bowel motility. However, limited evidence exists regarding its effectiveness in postpartum women, necessitating further investigation

Read the detailed description

to evaluate the effect of electroacupuncture on improving bowel function and reducing symptoms of postpartum constipation compared to standard care.

Study population \& Sample size: (no more than 3 lines) Postpartum women aged 20-40 years diagnosed with constipation. A randomized controlled trial with two parallel groups: an electroacupuncture group and a control group receiving abdominal exercises . Participants will be randomly assigned using a simple randomization method.

Diagnosis:

Postpartum constipation diagnosed based on clinical criteria (e.g., Rome IV criteria).

Groups:

  • Group A: Electroacupuncture + abdominal exercises
  • Group B: abdominal exercises only

Inclusion Criteria:

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • Contraindications to acupuncture (tumor, scar or keloids \& spinal instability ).

Measuring Tools:

  1. Bristol Stool Form Scale This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.
  2. Patient Assessment of Constipation Quality of Life (PAC-QOL) This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.

    • Evaluation procedures All participants will undergo a standardized evaluation before and after the intervention period. Baseline assessment will be conducted prior to randomization to ensure comparability between groups.

At the beginning of the study, demographic and clinical data will be collected, including age, parity, mode of delivery, and time since delivery. Participants will then be evaluated for constipation severity and bowel habits.

Stool consistency will be assessed using the Bristol Stool Form Scale, where participants will classify their stool type according to the seven-point scale. In addition, participants will be instructed to record bowel movement frequency per week using a bowel diary.

Quality of life related to constipation will be evaluated using the Patient Assessment of Constipation Quality of Life (PAC-QOL) questionnaire. This tool will assess the physical, psychological, and social impact of constipation on daily living.

All outcome measures will be recorded at baseline (pre-treatment) and at the end of the treatment period (post-treatment). Participants will also be monitored throughout the study to ensure compliance and to document any adverse effects.

  • Treatment procedures The electroacupuncture group will receive treatment sessions 3 times per week for 6 weeks using Quchi (LI11) and Shangjuxu (ST37) acupoints added to abdominal exercises . The control group will receive abdominal exercises only.
02

Conditions studied

  • Postpartum Constipation

Browse trials for

03

In context

Constipation

1,046 studies on the registry are indexed under Constipation; 161 are open to participants now.

This study's planned enrollment of 60 is below the median of 75 across 884 interventional studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

MTI University is the lead sponsor of 61 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion criteria

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • to acupuncture (tumor, scar or keloids \& spinal instability ).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    electro acupuncture group

    Participants in this group will receive electroacupuncture therapy applied to Quchi (LI11) and Shangjuxu (ST37) acupoints plus abdominal exercises Treatment will be administered \[12 sessions per week\] for \[6 weeks\], with each session lasting approximately \[30 minutes\]. The intervention aims to improve bowel function in postpartum constipation.

    Other: electroacupuncture · Other: abdominal exercises for constipation

  • Active comparator
    control group

    Participants in this group will perform a structured abdominal exercise program designed to improve bowel motility. Exercises will be conducted \[12 sessions per week\] for \[6 weeks\], with each session lasting approximately \[20 minutes\].

    Other: abdominal exercises for constipation

Interventions

  • Otherelectroacupuncture

    This study is expected to contribute significantly to maternal healthcare in Egypt by addressing postpartum constipation, a common yet often neglected condition affecting women after childbirth. Constipation can negatively impact quality of life, causing discomfort, pain, and psychological distress. Electroacupuncture offers a safe, non-pharmacological, and cost-effective treatment alternative. This is particularly important for postpartum women who may avoid medications due to breastfeeding concerns or side effects. The findings of this study may support the integration of electroacupuncture into routine postpartum care in Egypt, especially within physical therapy and rehabilitation programs. It may also help reduce dependence on laxatives and improve patient satisfaction.

  • Otherabdominal exercises for constipation

    Static Abdominal Contractions Lie on your back in "crook lying" (knees bent, feet flat). Gently contract all abdominal muscles (as if bracing for a light punch), hold 5-10 seconds, then release. Repeat. Keep breathing normally. This strengthens the abdominal wall to improve bowel support and tone. Activation and exercise of the transverse abdominis muscle has been noted as important, as it brings together the bellies of the rectus abdominus muscle, improving the integrity of the linea alba and increasing fascial tension. While studied primarily for diastasis recti, these exercises engage the deep core and can support improved abdominal function overall.

06

What researchers measure

Primary outcomes

  1. Bristol Stool Form Scale

    This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.

    Time frame: 6 weeks

  2. Patient Assessment of Constipation Quality of Life (PAC-QOL)

    This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Aug 2026, 3 months later.

Of 243 non-industry interventional studies with no phase under Constipation, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's planned 3 months is below that.

Counting every sponsor, half of 314 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2026
First posted
May 7, 2026
StartEst.
May 20, 2026
Primary completionEst.
Aug 20, 2026
CompletionEst.
Oct 20, 2026
Last update
May 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07572786
Lead sponsor
MTI University
Responsible party
shaimaa Mohamed hamed (Lecturer, MTI University) — Principal investigator
First posted
May 7, 2026
Start date
May 20, 2026 (estimated)
Primary completion
Aug 20, 2026 (estimated)
Completion
Oct 20, 2026 (estimated)
Last update
May 7, 2026

Study contacts

shaimaa MH elmarakby
Contact
shaimaa.mohamed@pt.mti.edu.eg
01008585299

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion